Tirzepatide (10 x vials)

CA$230.00

Tirzepatide, a medication used for managing type 2 diabetes and obesity. Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.

Uses of Tirzepatide

  1. Type 2 Diabetes Management:

    • Blood Sugar Control: Tirzepatide helps in lowering blood sugar levels by enhancing insulin secretion when blood sugar is high and reducing glucagon secretion.
    • HbA1c Reduction: It effectively reduces HbA1c levels, which is a measure of average blood glucose over the past three months.
    • Weight Loss: Tirzepatide can aid in weight loss, which is beneficial for many people with type 2 diabetes.
  2. Weight Management and Obesity:

    • Appetite Suppression: Tirzepatide helps reduce appetite and increase feelings of fullness, leading to reduced food intake.
    • Weight Loss: It is being studied and used for chronic weight management for individuals with obesity or overweight individuals with weight-related conditions.
  3. Cardiovascular Benefits:

    • Heart Health: Some studies suggest that tirzepatide can reduce the risk of major cardiovascular events, such as heart attack and stroke, in people with type 2 diabetes who have established cardiovascular disease.

Mechanism of Action

Tirzepatide works by mimicking the effects of two incretin hormones, GIP and GLP-1, which play a role in glucose metabolism and appetite regulation. By activating both GIP and GLP-1 receptors, tirzepatide helps:

  • Increase insulin secretion from the pancreas in response to meals.
  • Decrease glucagon release, a hormone that raises blood glucose levels.
  • Slow gastric emptying, leading to reduced appetite and caloric intake.
  • Promote weight loss through its effects on appetite and satiety centers in the brain.

Administration

Tirzepatide is administered as an injectable medication, typically once weekly.

Brand Name

Tirzepatide is marketed under the brand name Mounjaro.